Cary Street Partners Investment Advisory’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,000
Closed -$5.45K 1359
2023
Q3
$5.45K Hold
1,000
﹤0.01% 1454
2023
Q2
$9.26K Hold
1,000
﹤0.01% 1261
2023
Q1
$8.22K Hold
1,000
﹤0.01% 1198
2022
Q4
$11.1K Buy
+1,000
New +$11.6K ﹤0.01% 1123
2022
Q3
Sell
-10,555
Closed -$161K 539
2022
Q2
$161K Buy
10,555
+1,000
+10% +$18K 0.01% 455
2022
Q1
$205K Sell
9,555
-60
-0.6% -$1.29K 0.06% 262
2021
Q4
$227K Buy
+9,615
New +$206K 0.06% 236
2021
Q3
Sell
-9,606
Closed -$193K 285
2021
Q2
$193K Buy
+9,606
New +$205K 0.06% 244
2020
Q4
Sell
-11,255
Closed -$198K 672
2020
Q3
$198K Buy
+11,255
New +$209K 0.04% 262

Other funds holding MPT

Cary Street Partners Investment Advisory's MPT Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Medical Properties Trust (MPT) in Q4 2023, closing a stake of 1,000 shares — an estimated $5.45K sold.

Cary Street Partners Investment Advisory first reported a position in MPT in Q3 2020 and held it in 9 quarters. The position peaked at $227K in Q4 2021. 551 funds tracked by Wall St. Rank hold MPT as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Medical Properties Trust position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 1,000 Medical Properties Trust shares in Q4 2023, an estimated $5.45K.
  • Cary Street Partners Investment Advisory first reported a position in Medical Properties Trust in Q3 2020 and held it in 9 quarters.
  • Cary Street Partners Investment Advisory's Medical Properties Trust position peaked at $227K in Q4 2021.
  • 551 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.